145 related articles for article (PubMed ID: 20587851)
1. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
Martin M; Azzi A; Lin SX; Boivin G
Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
[TBL] [Abstract][Full Text] [Related]
3. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
4. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T; Fuller MD; Cherrington JM
J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
[TBL] [Abstract][Full Text] [Related]
5. [A novel colorimetric test to study the susceptibility of human cytomegalovirus DNA polymerase to foscarnet].
Ducancelle A; Alain S; Scieux C; Fillet AM; Petit F; Sanson-Le Pors MJ; Mazeron MC
Pathol Biol (Paris); 2005; 53(8-9):551-5. PubMed ID: 16084026
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
Martin M; Goyette N; Boivin G
J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
[TBL] [Abstract][Full Text] [Related]
8. Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.
Tchesnokov EP; Gilbert C; Boivin G; Götte M
J Virol; 2006 Feb; 80(3):1440-50. PubMed ID: 16415021
[TBL] [Abstract][Full Text] [Related]
9. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
[TBL] [Abstract][Full Text] [Related]
12. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.
Chou S; Lurain NS; Thompson KD; Miner RC; Drew WL
J Infect Dis; 2003 Jul; 188(1):32-9. PubMed ID: 12825168
[TBL] [Abstract][Full Text] [Related]
13. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
[TBL] [Abstract][Full Text] [Related]
14. Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
Zarrouk K; Pham VD; Piret J; Shi R; Boivin G
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015044
[TBL] [Abstract][Full Text] [Related]
15. [Development of drug-resistant human cytomegalovirus].
Murayama T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():508-11. PubMed ID: 16615525
[No Abstract] [Full Text] [Related]
16. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Chou S; Miner RC; Drew WL
J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterisation of cytomegalovirus DNA polymerase: a method to study cytomegalovirus isolates resistant to foscarnet.
Ducancelle A; Gravisse J; Alain S; Fillet AM; Petit F; Pors MJ; Mazeron MC
J Virol Methods; 2005 May; 125(2):145-51. PubMed ID: 15794984
[TBL] [Abstract][Full Text] [Related]
18. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
[TBL] [Abstract][Full Text] [Related]
19. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
20. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.
Michel D; Höhn S; Haller T; Jun D; Mertens T
J Med Virol; 2001 Sep; 65(1):70-6. PubMed ID: 11505446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]